ArticlePatient preference and adherence2021

Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy.

Giuseppe Argenziano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.